“Treatment decisions for people with major depressive disorder are challenging, particularly for patients who have already not benefitted from one or more medications,” said Michael E. Thase M.D., ...

Myriad Genetics, Inc. MYGN recently published results from a meta-analysis in the Journal of Clinical Psychopharmacology, stating the superiority of the company’s GeneSight Psychotropic test over ...

The combinatorial, multi-gene GeneSight test has been found to better predict antidepressant treatment outcomes for patients with depression, and their use of health care resources, than any of the ...

In today's world, personalization is the norm. From curated music playlists and tailored shopping recommendations to customized social media feeds, the culture is now shaped around individual ...

The GeneSight test analyzes clinically important genetic variations in your DNA. The results of the test can inform your doctor about genes that may impact how you metabolize or respond to certain ...

YORK, Pa. — A simple cheek swab claims to give patients an individualized look at which medications are best suited for their mental health, based on their DNA. "There may be an issue where ...

“For three years, it was like throwing darts at a dartboard – except, I was the dartboard,” said Ronni, whose acute suffering persisted as she and her health care providers searched for medication to ...

On Monday, in its earnings release, Myriad Genetics Inc. (NASDAQ:MYGN) said Unitedhealth Group Inc’s (NYSE:UNH) UnitedHealthcare will stop covering multi-gene panel pharmacogenetic testing, including ...

SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...

Women are nearly twice as likely to develop major depression than men. Causes of depression are often unknown, but several factors may increase a woman’s risk of depression. These factors include ...

Mason, Ohio - August 12, 2015 - A new study published in Current Medical Research and Opinion demonstrated $1,036 in annual prescription savings per patient when healthcare providers used the ...